More News

02 Feb 2007 Pfizer to Acquire BioRexis to Access Novel Technology Platform and Early Stage Diabetes Pipeline
02 Feb 2007 AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
02 Feb 2007 Successful Oral Insulin Toxicity Result - Oradel(TM), Loaded With Generic Insulin
02 Feb 2007 Galapagos announces PPAR-delta commercial license agreement with Hillcrest Therapeutics
01 Feb 2007 Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
01 Feb 2007 AstraZeneca and Palatin Technologies Announce Worldwide Collaboration to Discover, Develop and Commercialise Obesity Compounds
01 Feb 2007 MediVas Announces Agreement with Merck in Area of Biologics
01 Feb 2007 MediVas Announces Agreement with Merck in Area of Biologics
01 Feb 2007 Lab International Initiates Patient Enrollment In The Extension Of Its Phase IIB Fentanyl Taifun(R) Trial
01 Feb 2007 Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
01 Feb 2007 NeuroDerm's Transdermal L-DOPA Parkinson’s Patch Completes First Clinical Trial
01 Feb 2007 Argenta Discovery and AstraZeneca Sign a Research Collaboration and Licensing Agreement to Discover Improved Bronchodilators for COPD
31 Jan 2007 OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
31 Jan 2007 Debiopharm Signs R&D And Commercialisation Agreement With Kirin For The Development Of DEBIO-0719 In Oncology
31 Jan 2007 Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
31 Jan 2007 BioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical Study
31 Jan 2007 Teva Receives Approval for Generic Focalin(TM) Tablets
31 Jan 2007 First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
30 Jan 2007 GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
30 Jan 2007 Par Pharmaceutical Receives Approval Of Generic Inderal-LA(R)
30 Jan 2007 Aurobindo bags one more cephalosporin from USFDA
30 Jan 2007 OccuLogix's RHEO-AMD Trial Protocol Cleared by the FDA
26 Jan 2007 Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir
26 Jan 2007 Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up